Is CT 01 safe to use alone or combined with Everolimus for inoperable advanced liver cancer?

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 154
• 16 sites in 3 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with advanced liver cancer (hepatocellular carcinoma) that cannot be removed by surgery. It tests CT 01 alone or together with Everolimus.

Age

18 years or older

Sex

Women and men can join.

Disease stage

Advanced liver cancer (hepatocellular carcinoma) that cannot be operated on.

Main reasons for not taking part

• Healthy volunteers cannot join.

Read by machine on 9 Nov 2026.

Sites (16)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details